The HRP-conjugated antibody is used to study UBE2L3’s role in:
Protein Degradation: Mediates ubiquitination of short-lived or abnormal proteins via interactions with E3 ligases (e.g., E6-AP, c-Cbl) .
NF-κB Signaling: Critical in TNFα-induced linear ubiquitination of NEMO, enabling IKK complex activation and proinflammatory cytokine production .
Mitophagy: Essential for Parkin-dependent mitophagy in neuronal cells .
| Sample Type | Species | Applications | Source |
|---|---|---|---|
| HeLa cells | Human | WB, IP, IHC | |
| Mouse kidney/testis | Mouse | WB, IP, IHC | |
| Human lung cancer | Human | IHC (with antigen retrieval) | |
| Platelets | Human | WB (thrombosis studies) |
TNFα Signaling: UBE2L3 knockdown reduces TNFα-induced linear ubiquitination of NEMO, impairing NF-κB activation and cytokine transcription (e.g., IL-8, IL-6) .
Autoimmune Diseases: Genetic variants in UBE2L3 are linked to systemic lupus erythematosus (SLE), rheumatoid arthritis, and Crohn’s disease, correlating with enhanced UBE2L3 expression .
LUBAC Complex Interaction: UBE2L3 associates with HOIL-1L in the linear ubiquitin chain assembly complex (LUBAC), enabling linear polyubiquitination of NEMO in vivo .
Distinctive E2 Activity: Unlike UBE2D3, UBE2L3 activates NF-κB reporters and interacts with LUBAC components, establishing its specificity in linear ubiquitination .
UBE2L3’s elevated expression in autoimmune diseases suggests its utility as a diagnostic marker or therapeutic target .